EMVision Medical Devices Ltd
ASX:EMV.AX
2.05 (AUD) • At close September 18, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) AUD.
| 2024 Q4 | 2024 Q2 | 2023 Q4 | 2023 Q2 | 2022 Q4 | 2022 Q2 | 2021 Q4 | 2021 Q2 | 2020 Q4 | 2020 Q2 | 2019 Q4 | 2019 Q3 | 2019 Q2 | 2018 Q4 | 2018 Q2 | 2018 Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 0 | 6.646 | 2.029 | 4.944 | 0.93 | 3.43 | 0.056 | 1.643 | 0.427 | 1.124 | 0.739 | 0 | 0.676 | 0.493 | 0 | 0 |
| Cost of Revenue
| 0.208 | 0.203 | 0.189 | 0.153 | 0.131 | 0.113 | 0.1 | 0.014 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Gross Profit
| -0.208 | 6.443 | 1.84 | 4.791 | 0.799 | 3.318 | -0.044 | 1.629 | 0.427 | 1.124 | 0.739 | 0 | 0.676 | 0.493 | 0 | 0 |
| Gross Profit Ratio
| 0 | 0.969 | 0.907 | 0.969 | 0.86 | 0.967 | -0.792 | 0.992 | 1 | 1 | 1 | 0 | 1 | 1 | 0 | 0 |
| Reseach & Development Expenses
| 2.843 | 1.854 | 1.223 | 0.789 | 1.264 | 1.062 | 1.065 | 1.643 | 1.184 | 1.751 | 1.084 | 0.49 | 0.876 | 0.676 | 0.28 | 0.14 |
| General & Administrative Expenses
| 0 | 0.897 | 0.846 | 0.681 | 0.613 | 0.675 | 0.54 | 0.417 | 0.287 | 0.44 | 0.394 | 0.498 | 0.348 | 0.166 | 0.032 | 0.016 |
| Selling & Marketing Expenses
| 0 | 3.376 | 2.957 | 4.091 | 2.998 | 3.613 | 3.599 | 2.807 | 0.709 | 0.741 | 0.033 | 0.033 | 0.033 | 0.092 | 0 | 0 |
| SG&A
| 4.096 | 4.273 | 3.803 | 4.772 | 3.611 | 4.288 | 4.139 | 3.223 | 0.997 | 1.181 | 0.98 | 0.531 | 1.433 | 0.349 | 0.032 | 0.016 |
| Other Expenses
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -0.949 | -0.949 | -0.949 | 0 | 0 | 0 |
| Operating Expenses
| 6.939 | 6.127 | 5.025 | 5.561 | 4.874 | 5.35 | 5.205 | 4.866 | 2.181 | 2.933 | 2.064 | 0.072 | 2.309 | 1.025 | 0.312 | 0.156 |
| Operating Income
| -7.147 | -6.33 | -5.215 | -5.713 | -5.005 | -5.462 | -5.305 | -4.88 | -2.181 | -2.933 | -2.064 | -1.093 | -1.633 | -0.532 | -0.312 | -0.156 |
| Operating Income Ratio
| 0 | -0.952 | -2.57 | -1.156 | -5.382 | -1.592 | -95.011 | -2.97 | -5.103 | -2.609 | -2.794 | 0 | -2.417 | -1.08 | 0 | 0 |
| Total Other Income Expenses Net
| 2.346 | 2.252 | 2.103 | 2.454 | 0.925 | 1.442 | 0.118 | 0.387 | 0.51 | 0.47 | 0.459 | 0.353 | -0 | -0 | -0 | -0 |
| Income Before Tax
| -4.801 | -4.078 | -3.112 | -3.26 | -4.08 | -4.02 | -5.187 | -4.492 | -1.67 | -2.463 | -1.605 | -0.74 | -1.634 | -0.533 | -0.312 | -0.156 |
| Income Before Tax Ratio
| 0 | -0.614 | -1.534 | -0.659 | -4.387 | -1.172 | -92.901 | -2.734 | -3.909 | -2.191 | -2.172 | 0 | -2.418 | -1.081 | 0 | 0 |
| Income Tax Expense
| -2.184 | -3.965 | 0 | -2.501 | -0 | -1.99 | 0 | -1.281 | -1.753 | -0.658 | -0.279 | 0 | -0 | -0 | -0 | -0 |
| Net Income
| -2.617 | -0.113 | -3.112 | -0.759 | -4.08 | -2.03 | -5.187 | -3.212 | -1.67 | -1.805 | -1.326 | -0.74 | -1.634 | -0.533 | -0.312 | -0.156 |
| Net Income Ratio
| 0 | -0.017 | -1.534 | -0.153 | -4.387 | -0.592 | -92.901 | -1.955 | -3.909 | -1.606 | -1.794 | 0 | -2.418 | -1.081 | 0 | 0 |
| EPS
| -0.031 | -0.001 | -0.04 | -0.009 | -0.053 | -0.028 | -0.072 | -0.046 | -0.026 | -0.03 | -0.023 | -0.016 | -0.045 | -0.018 | -0.028 | -0.014 |
| EPS Diluted
| -0.031 | -0.001 | -0.04 | -0.009 | -0.053 | -0.028 | -0.072 | -0.046 | -0.026 | -0.03 | -0.023 | -0.016 | -0.045 | -0.018 | -0.028 | -0.014 |
| EBITDA
| -6.939 | -6.127 | -5.025 | -5.561 | -4.874 | -5.35 | -5.205 | -4.866 | -2.181 | 0.003 | -0 | -0.74 | -0 | -0 | -0 | -0 |
| EBITDA Ratio
| 0 | -0.922 | -2.476 | -1.125 | -5.241 | -1.559 | -93.219 | -2.962 | -5.103 | 0.003 | -0 | 0 | -0.001 | -0.001 | 0 | 0 |